For more publications, click here to check our Google Scholar.
Charles Hesswani, Chelsea L. Jackson, Gautier Marcq, Céline Hardy, Ronald Kool, Jose Joao Mansure, Fadi Brimo, David M. Berman, Wassim Kassouf, Feasibility and Impact of Immunohistochemistry-based Molecular Subtyping for Muscle-invasive Bladder Cancer in Patients Treated with Radiation-based Therapy, European Urology Open Science, Volume 57, 2023, Pages 22-29, ISSN 2666-1683, https://doi.org/10.1016/j.euros.2023.09.003.
Silvertown, J.D., Lisle, C., Semenuk, L. et al. Prevalence of NTRK Fusions in Canadian Solid Tumour Cancer Patients. Mol Diagn Ther 27, 87–103 (2023). https://doi.org/10.1007/s40291-022-00617-y
Hardy, C., Ghaedi, H., Slotman, A., Sjödahl, G., Gooding, R. J., Berman, D. M., & Jackson, C. (2022). Immunohistochemical assays for bladder Cancer Molecular Subtyping: Optimizing parsimony and performance of Lund taxonomy classifiers. Journal of Histochemistry and Cytochemistry, 70(5), 357–375. https://doi.org/10.1369/00221554221095530
Booth CM, Siemens DR, Li G, Peng Y, Tannock IF, Kong W, Berman DM, and Mackillop, WJ (2014) Peri-Operative Chemotherapy for Muscle-Invasive Bladder Cancer: A Population-Based Outcomes Study. Cancer, 120(11): 1630-8. doi: 10.1002/cncr.28510.
Carvalho FLF, Simons BW, Eberhart CG and Berman DM (2014), Notch signaling in prostate cancer: A moving target. Prostate, 74: 933–945. doi: 10.1002/pros.22811.
Lotan TL, Carvalho FL, Peskoe SB, Hicks JL, Good J, Fedor HL, Humphreys E, Han M, Platz EA, Squire JA, De Marzo AM, Berman DM (2014) PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy. Mod Pathol, 28(1): 128-137. doi: 10.1038/modpathol.2014.85.
Bellmunt J, Selvarajah S, Rodig S, Salido M, de Muga S, Costa I, Bellosillo B, Werner L, Mullane S, Fay AP, O’Brien R, Barretina J, Minoche AE, Signoretti S, Montagut C, Himmelbauer H, Berman DM, Kantoff P, Choueiri TK, Rosenberg JE (2014) Identification of ALK gene alterations in urothelial carcinoma. PLoS ONE 9(8): e103325. doi: 10.1371/journal.pone.0103325.
Booth CM, Siemens DR, Wei X, Peng Y, Berman DM, Mackillop WJ (2014) Pathologic Factors Associated with Survival Benefit From Adjuvant Chemotherapy: A Population-Based Study of Bladder Cancer. BJU Int, 116(3): 373-81. doi: 10.1111/bju.12913.
Berman DM, Kawashima A, Peng Y, Mackillop WJ, Siemens DR, Booth CM (2014) Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: A population-based study. Int J Urol, 22: 163–170. doi: 10.1111/iju.12611.
Carvalho FLF, Marchionni L, Gupta A, Kummangal BA, Schaeffer EM, Ross AE, Berman DM (2015), HES6 promotes prostate cancer aggressiveness independently of Notch signalling. J Cell Mol Med, 19: 1624–1636. doi: 10.1111/jcmm.12537.
Patel PG, Selvarajah S, Boursalie S, How N, Ejdelman J, Guérard KP, Bartlett JMS, Lapointe J, Park PC, Okello JBA, Berman DM (2016) Preparation of Formalin-Fixed Paraffin-Embedded Tissue Cores for Optimized Extraction of RNA and DNA. J Vis Exp, 114: 54299. doi:10.3791/54299.
Patel PG, Selvarajah S, Guérard KP, Bartlett JMS, Lapointe J, Berman DM, Okello JBA, Park PC (2017) Reliability and performance of commercial RNA and DNA extraction kits for FFPE tissue cores. PLoS ONE, 12(6): e0179732. 10.1371/journal.pone.0179732.